These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23337216)

  • 1. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
    Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
    Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
    Wang YT; Huang G
    Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
    Harewood GC; Wiersema MJ; Edell ES; Liebow M
    Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
    Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
    Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.
    De Leyn P; Lardinois D; Van Schil PE; Rami-Porta R; Passlick B; Zielinski M; Waller DA; Lerut T; Weder W
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):1-8. PubMed ID: 17448671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.
    Yap KK; Yap KS; Byrne AJ; Berlangieri SU; Poon A; Mitchell P; Knight SR; Clarke PC; Harris A; Tauro A; Rowe CC; Scott AM
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1033-40. PubMed ID: 15875178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
    Muehling B; Wehrmann C; Oberhuber A; Schelzig H; Barth T; Orend KH
    Ann Surg Oncol; 2012 Jan; 19(1):89-93. PubMed ID: 21755379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.
    Yasufuku K; Pierre A; Darling G; de Perrot M; Waddell T; Johnston M; da Cunha Santos G; Geddie W; Boerner S; Le LW; Keshavjee S
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1393-400.e1. PubMed ID: 21963329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy.
    Aabakken L; Silvestri GA; Hawes R; Reed CE; Marsi V; Hoffman B
    Endoscopy; 1999 Nov; 31(9):707-11. PubMed ID: 10604611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.
    Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R
    Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
    Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
    J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multidisciplinarity of stage III non-small cell lung cancer.
    Vansteenkiste J; Dooms C; De Leyn P
    Eur J Cancer; 2009 Sep; 45 Suppl 1():92-105. PubMed ID: 19775608
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
    Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
    Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada.
    Sloka JS; Hollett PD; Mathews M
    Med Sci Monit; 2004 May; 10(5):MT73-80. PubMed ID: 15114279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.